X-103063171-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The ENST00000372728.4(BEX1):c.104C>T(p.Ala35Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000423 in 1,209,789 control chromosomes in the GnomAD database, including 1 homozygotes. There are 179 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000372728.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BEX1 | NM_018476.4 | c.104C>T | p.Ala35Val | missense_variant | 3/3 | ENST00000372728.4 | NP_060946.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BEX1 | ENST00000372728.4 | c.104C>T | p.Ala35Val | missense_variant | 3/3 | 1 | NM_018476.4 | ENSP00000361813 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000215 AC: 24AN: 111536Hom.: 0 Cov.: 22 AF XY: 0.0000890 AC XY: 3AN XY: 33726
GnomAD3 exomes AF: 0.000218 AC: 40AN: 183199Hom.: 0 AF XY: 0.000251 AC XY: 17AN XY: 67697
GnomAD4 exome AF: 0.000444 AC: 488AN: 1098201Hom.: 1 Cov.: 31 AF XY: 0.000484 AC XY: 176AN XY: 363555
GnomAD4 genome AF: 0.000215 AC: 24AN: 111588Hom.: 0 Cov.: 22 AF XY: 0.0000888 AC XY: 3AN XY: 33788
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.104C>T (p.A35V) alteration is located in exon 3 (coding exon 1) of the BEX1 gene. This alteration results from a C to T substitution at nucleotide position 104, causing the alanine (A) at amino acid position 35 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | BEX1: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at